Long Yuan

Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Role of Tryptophan Metabolism in Cancer.

Role of Tryptophan Metabolism in Cancer.

Journal: Cancer innovation

Published: January 23, 2025

Corrigendum to "Effects of gold nanostructures on differentiation of mesenchymal stem cells" [Colloid. Surf. B: Biointerfaces 184 (2019) 110494].

Corrigendum to "Effects of gold nanostructures on differentiation of mesenchymal stem cells" [Colloid. Surf. B: Biointerfaces 184 (2019) 110494].

Journal: Colloids and surfaces. B, Biointerfaces

Published: December 22, 2024

Taxane combined with lobaplatin or anthracycline for neoadjuvant chemotherapy of triple-negative breast cancer: a randomized, controlled, phase II study.

Taxane combined with lobaplatin or anthracycline for neoadjuvant chemotherapy of triple-negative breast cancer: a randomized, controlled, phase II study.

Journal: BMC medicine

Published: October 17, 2023

Effect of empathy competence on moral sensitivity in Chinese student nurses: the mediating role of emotional intelligence.

Effect of empathy competence on moral sensitivity in Chinese student nurses: the mediating role of emotional intelligence.

Journal: BMC nursing

Published: June 24, 2023

Two Hematological Markers Predicting the Efficacy and Prognosis of Neoadjuvant Chemotherapy Using Lobaplatin Against Triple-Negative Breast Cancer.

Two Hematological Markers Predicting the Efficacy and Prognosis of Neoadjuvant Chemotherapy Using Lobaplatin Against Triple-Negative Breast Cancer.

Journal: The oncologist

Published: May 31, 2023

A multicenter single-arm trial of neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancer.

A multicenter single-arm trial of neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancer.

Journal: MedComm

Published: April 10, 2023

Dramatic Response to Pyrotinib and T-DM1 in HER2-Negative Metastatic Breast Cancer With 2 Activating HER2 Mutations.

Dramatic Response to Pyrotinib and T-DM1 in HER2-Negative Metastatic Breast Cancer With 2 Activating HER2 Mutations.

Journal: The oncologist

Published: February 09, 2023

A Prospective Self-Controlled Study of Indocyanine Green, Radioisotope, and Methylene Blue for Combined Imaging of Axillary Sentinel Lymph Nodes in Breast Cancer.

A Prospective Self-Controlled Study of Indocyanine Green, Radioisotope, and Methylene Blue for Combined Imaging of Axillary Sentinel Lymph Nodes in Breast Cancer.

Journal: Frontiers in oncology

Published: October 28, 2021

Integrated endotoxin-adsorption and antibacterial properties of platelet-membrane-coated copper silicate hollow microspheres for wound healing.

Integrated endotoxin-adsorption and antibacterial properties of platelet-membrane-coated copper silicate hollow microspheres for wound healing.

Journal: Journal of nanobiotechnology

Published: September 13, 2021

Chiral nanomaterials for tumor therapy: autophagy, apoptosis, and photothermal ablation.

Chiral nanomaterials for tumor therapy: autophagy, apoptosis, and photothermal ablation.

Journal: Journal of nanobiotechnology

Published: May 07, 2021

A Review of Recent Advances in Nanomaterial-based Stem Cell Therapy and the Corresponding Risks.

A Review of Recent Advances in Nanomaterial-based Stem Cell Therapy and the Corresponding Risks.

Journal: Current stem cell research & therapy

Published: December 02, 2020

Comparative efficacy, safety, and acceptability of single-agent poly (ADP-ribose) polymerase (PARP) inhibitors in BRCA-mutated HER2-negative metastatic or advanced breast cancer: a network meta-analysis.

Comparative efficacy, safety, and acceptability of single-agent poly (ADP-ribose) polymerase (PARP) inhibitors in BRCA-mutated HER2-negative metastatic or advanced breast cancer: a network meta-analysis.

Journal: Aging

Published: April 16, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026